/ /

Tracey Walker
Four ways health execs can prep for costly CAR-T cell therapies
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
Study: Formularies may be key to alleviating opioid epidemic
New Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.
Medicare Advantage vs. specialized Medicare Advantage plans: Outcome effects
Avalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.
Many hospitals not sharing e-patient data
Why researchers say the industry is “a long way off” from robust electronic patient data sharing.
Trump’s steps to undo the ACA: Top takeaways from healthcare insiders
Trump takes two steps to dissolve the ACA. Find out what the experts think about these two important actions.
Five ways Trump’s efforts to strip the ACA will affect healthcare
Here’s a quick guide to the meaning behind Trump’s executive order and decision to stop cost-sharing reduction payments.
FDA challenges abuse-deterrent opioid drug claim
The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.
Do antidepressants take more lives than they save?
An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
Payments to specialists could yo-yo under MIPS
Avalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.
Two opioid use disorder drug developments to watch
New physician-administered therapies on the horizon may help rein in the opioid epidemic.